Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Prostate Neoplasm”

231 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 231 results

Not applicableNot Yet RecruitingNCT07238959
What this trial is testing

Application of Quantum Detection-Driven Artificial Intelligence Algorithms for Single-Molecule cfDNA Characterization in the Early Diagnosis of Prostate Cancer

Who this might be right for
Benign Prostate Hypertrophy(BPH)Prostate Cancer (Diagnosis)Prostate Neoplasm
Shanghai Changzheng Hospital 1,100
Early research (Phase 1)Study completedNCT03205176
What this trial is testing

AZD5153 in Patients With Relapsed or Refractory Solid Tumors, Including Lymphomas

Who this might be right for
Malignant Solid TumorsLymphomaOvarian Cancer+3 more
AstraZeneca 49
Not applicableLooking for participantsNCT06982469
What this trial is testing

High Dose Rate (HDR) Brachytherapy Salvage After Prostatectomy

Who this might be right for
Prostate CancerProstatectomyLocal Recurrence of Malignant Tumor of Prostate+2 more
Clinica Universidad de Navarra, Universidad de Navarra 20
Not applicableActive Not RecruitingNCT03438552
What this trial is testing

Efficacy of Repeat Stereotactic Radiation in Patients With Intraprostatic Tumor Recurrence

Who this might be right for
Local Recurrence of Malignant Tumor of Prostate
UNICANCER 57
Early research (Phase 1)WithdrawnNCT01320787
What this trial is testing

18-F-Fluoroacetate as PET Imaging Agent

Who this might be right for
Brain CancerBreast CancerProstate Cancer
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT04585750
What this trial is testing

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Who this might be right for
Advanced Solid TumorAdvanced Malignant NeoplasmMetastatic Cancer+27 more
PMV Pharmaceuticals, Inc 300
Testing effectiveness (Phase 2)WithdrawnNCT05191017
What this trial is testing

Study of NUV-422 in Combination With Enzalutamide in Patients With mCRPC

Who this might be right for
Prostate CancerProstatic CancerCancer of Prostate+5 more
Nuvation Bio Inc.
Early research (Phase 1)Active Not RecruitingNCT04457232
What this trial is testing

Prospective Exploratory Study of FAPi PET/CT in Prostate Cancer With Histopathology Validation

Who this might be right for
Metastatic Malignant Neoplasm in the Prostate GlandProstate CarcinomaRecurrent Prostate Carcinoma
Jonsson Comprehensive Cancer Center 30
Testing effectiveness (Phase 2)WithdrawnNCT05582031
What this trial is testing

Regorafenib With Tislelizumab in Patients With Selected Mismatch Repair-Proficient/Microsatellite Stable Cancers

Who this might be right for
Anal Squamous Cell CarcinomaColorectal NeoplasmsSoft Tissue Sarcoma+5 more
Translational Research in Oncology
Testing effectiveness (Phase 2)Study completedNCT04019327
What this trial is testing

The Drugs Talazoparib and Temozolomide in Prostate Cancer

Who this might be right for
Prostate CancerProstate AdenocarcinomaProstate Neoplasm+2 more
Memorial Sloan Kettering Cancer Center 16
Not applicableLooking for participantsNCT06223295
What this trial is testing

Effectiveness of Focal Therapy in Men With Prostate Cancer

Who this might be right for
Prostate CancerProstate Neoplasm
Radboud University Medical Center 356
Early research (Phase 1)Active Not RecruitingNCT03845166
What this trial is testing

XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors

Who this might be right for
Neoplasm MalignantRenal Cell CarcinomaHormone Receptor Positive Breast Carcinoma+2 more
Exelixis 325
Testing effectiveness (Phase 2)Looking for participantsNCT04071236
What this trial is testing

Radiation Medication (Radium-223 Dichloride) Versus Radium-223 Dichloride Plus Radiation Enhancing Medication (M3814) Versus Radium-223 Dichloride Plus M3814 Plus Avelumab (a Type of Immunotherapy) for Advanced Prostate Cancer Not Responsive to Hormonal Therapy

Who this might be right for
Metastatic Castration-Resistant Prostate CarcinomaMetastatic Malignant Neoplasm in the BoneMetastatic Malignant Neoplasm in the Lymph Nodes+1 more
National Cancer Institute (NCI)
Not applicableUnknownNCT04124107
What this trial is testing

Unfavorable MRI But Favorable 68Ga-PSMA PET/MRI for Primary Prostate Cancer Detection

Who this might be right for
Prostate Neoplasm
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 50
Not applicableLooking for participantsNCT06315595
What this trial is testing

Improvements in Dynamic Contrast-Enhanced MR Angiography and Perfusion and Non-Contrast MRI

Who this might be right for
Prostate Neoplasm
Mayo Clinic 1,000
Not applicableActive Not RecruitingNCT04761107
What this trial is testing

Impact of COVID-19 on GU Disease

Who this might be right for
COVID-19 InfectionGenitourinary CancerBenign Urologic Conditions
Icahn School of Medicine at Mount Sinai 15,240
Testing effectiveness (Phase 2)Looking for participantsNCT06574880
What this trial is testing

STereotActic Body Radiotherapy and 177Lutetium PSMA in Locally Advanced Prostate Cancer

Who this might be right for
Malignant Neoplasm of ProstateLocally Advanced Prostate Cancer
Angela Y. Jia, MD PhD 45
Early research (Phase 1)Study completedNCT00667641
What this trial is testing

Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+6 more
University of Medicine and Dentistry of New Jersey 16
Testing effectiveness (Phase 2)Active Not RecruitingNCT04045717
What this trial is testing

Hypofractionated Focal Lesion Ablative Microboost in prostatE Cancer 2.0

Who this might be right for
Prostate AdenocarcinomaProstate CancerProstate Neoplasm
Universitaire Ziekenhuizen KU Leuven 124
Early research (Phase 1)Ended earlyNCT02809690
What this trial is testing

18F-FMAU PET/CT in Diagnosing and Characterizing Prostate Cancer

Who this might be right for
Prostate Neoplasm
University of Southern California 18
Load More Results
90